soul trial oral semaglutide cardiovascular outcomes 2024 nejm Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 Oral Semaglutide and Cardiovascular Outcomes

Medication Impact / Treatment Medications used to treat pediatric risk-adjusting conditions both confirm the diagnosis and in some models directly trigger risk category assignment in CDPS+Rx (which includes pharmacy data)

Monarch Medicine is 10 minutes east on 116th Street with full urgent care capability, on-site imaging, and same-day results

To help manage symptoms effectively, consider our GLP-1 app to better monitor and understand your experiences

Whats incredible is that there was no struggle

Our team helps confirm what you need so your visit is smooth

BPC157 :New anti-inflammatory peptide | Seven Hills Medical Centr